Poor prognostic subgroup in T3N0 stage IIA gastric cancer, suggesting an indication for adjuvant chemotherapy

E-ISSN： 1096-9098|111|2|221-225

ISSN： 0022-4790

Source： JOURNAL OF SURGICAL ONCOLOGY, Vol.111, Iss.2, 2015-02, pp. : 221-225

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Adjuvant Chemotherapy in the Management of pT3N0M0 Transitional Cell Carcinoma of the Upper Urinary Tract

Urologia Internationalis, Vol. 77, Iss. 1, 2009-05 ,pp. : 22-26

Karger

Access to resources Recommend Favorite

Distinctive oncological features of stage IIIA colorectal cancer: Analysis of prognostic factors for selective adjuvant chemotherapy

JOURNAL OF SURGICAL ONCOLOGY, Vol. 111, Iss. 7, 2015-06 ,pp. : 882-890

John Wiley & Sons Inc

Access to resources Recommend Favorite

The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses

INTERNATIONAL JOURNAL OF CANCER, Vol. 137, Iss. 4, 2015-08 ,pp. : 819-825

John Wiley & Sons Inc

Access to resources Recommend Favorite

UBD and stage II colon cancer's chemotherapy

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 680-688

John Wiley & Sons Inc

Access to resources Recommend Favorite

Retrospective Analysis of Adjuvant Intraperitoneal Chemotherapy Effect Prognosis of Resectable Gastric Cancer

Oncology, Vol. 80, Iss. 5-6, 2011-07 ,pp. : 289-295

Karger

Access to resources Recommend Favorite